| Keyword | CPC | PCC | Volume | Score |
|---|---|---|---|---|
| cevostamab | 0.24 | 0.6 | 8572 | 71 |
| cevostamab multiple myeloma | 0.3 | 0.1 | 4176 | 72 |
| cevostamab mechanism of action | 0.37 | 0.9 | 2638 | 61 |
| cevostamab fda approval | 1.98 | 0.4 | 5351 | 58 |
| cevostamab side effects | 1.08 | 0.9 | 5956 | 37 |
| cevostamab crs | 1.36 | 0.5 | 974 | 22 |
| cevostamab pdf | 1.05 | 0.4 | 5154 | 7 |
| cevostamab rp2d | 1.97 | 0.1 | 1541 | 65 |
| cevostamab roche | 0.18 | 0.5 | 5930 | 18 |
| cevostamab target | 0.53 | 0.4 | 6514 | 49 |
| cevostamab myeloma | 1.45 | 1 | 1110 | 80 |
| cevostamab approval | 1.41 | 0.2 | 8572 | 100 |
